Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Achieve Life Sciences stock

Learn how to easily invest in Achieve Life Sciences stock.

Achieve Life Sciences Inc is a biotechnology business based in the US. Achieve Life Sciences shares (ACHV) are listed on the NASDAQ and all prices are listed in US Dollars. Achieve Life Sciences employs 16 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Achieve Life Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ACHV – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Achieve Life Sciences stock price (NASDAQ: ACHV)

Use our graph to track the performance of ACHV stocks over time.

Achieve Life Sciences shares at a glance

Information last updated 2022-09-18.
Latest market close$3.84
52-week range$4.35 - $10.09
50-day moving average $4.96
200-day moving average $6.56
Wall St. target price$31.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.66

Buy Achieve Life Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Achieve Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Achieve Life Sciences price performance over time

Historical closes compared with the close of $3.84 from 2022-09-23

1 week (2022-09-19) -11.52%
1 month (2022-08-26) -18.30%
3 months (2022-06-24) -27.00%
6 months (2022-03-24) -48.04%
1 year (2021-09-22) N/A
2 years (2020-09-25) -58.08%
3 years (2019-09-26) 94.92%
5 years (2017-09-26) 73.76%

Achieve Life Sciences financials

Gross profit TTM $0
Return on assets TTM -48.88%
Return on equity TTM -118.04%
Profit margin 0%
Book value $1.36
Market capitalisation $42.9 million

TTM: trailing 12 months

Achieve Life Sciences share dividends

We're not expecting Achieve Life Sciences to pay a dividend over the next 12 months.

Have Achieve Life Sciences's shares ever split?

Achieve Life Sciences's shares were split on a 1:20 basis on 30 July 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Achieve Life Sciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Achieve Life Sciences shares which in turn could have impacted Achieve Life Sciences's share price.

Achieve Life Sciences share price volatility

Over the last 12 months, Achieve Life Sciences's shares have ranged in value from as little as $4.35 up to $10.09. A popular way to gauge a stock's volatility is its "beta".

ACHV.US volatility(beta: 1.19)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Achieve Life Sciences's is 1.1866. This would suggest that Achieve Life Sciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Achieve Life Sciences overview

Achieve Life Sciences, Inc. , a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada. .

Frequently asked questions

What percentage of Achieve Life Sciences is owned by insiders or institutions?
Currently 0.469% of Achieve Life Sciences shares are held by insiders and 30.219% by institutions.
How many people work for Achieve Life Sciences?
Latest data suggests 16 work at Achieve Life Sciences.
When does the fiscal year end for Achieve Life Sciences?
Achieve Life Sciences's fiscal year ends in December.
Where is Achieve Life Sciences based?
Achieve Life Sciences's address is: 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1
What is Achieve Life Sciences's ISIN number?
Achieve Life Sciences's international securities identification number is: US0044685008
What is Achieve Life Sciences's CUSIP number?
Achieve Life Sciences's Committee on Uniform Securities Identification Procedures number is: 004468104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site